Ribosomal RNA (rRNA) transcription rates vary during development, and their dysregulation is linked to diseases such as cancer and ribosomopathies. Owing to their high abundance and genomic redundancy, the functional significance of rRNA-levels remains unclear. Here, we developed TAPIR (Targeted Activation of Protein Translation), a CRISPR-based approach to elevate rRNA-levels by inducing 47S rDNA transcription. TAPIR increased nucleolar size and enhanced protein synthesis, even in rapidly proliferating cells. In neural stem cells, elevated translation promoted self-renewal and proliferation in vitro and in vivo. Furthermore, TAPIR enabled the modeling and partial rescue of associated disease phenotypes. Our findings revealed that rRNA-levels directly regulate translational output and that protein synthesis capacity can act as a key determinant of mammalian stem cell behavior.
GrantsFritz Thyssen Foundation Stowers Institute for Medical Research The iNeuron Frontiers in Research Fund (NFRF) Transformation grant through Social Sciences and Humanities Research Council of Canada (SSHRC) Frontiers in Research Fund (NFRF) Transformation grant through Natural Sciences and Engineering Research Council of Canada and Social Sciences (NSERC) Frontiers in Research Fund (NFRF) Transformation grant through Canadian Institutes of Health Research (CIHR) EU/EIC (European Innovation Council) project REGENERAR Epiadapt DFG networks SFB 1064 Munich Cluster for Systems Neurology (SyNergy) Cancer Research UK Programme Foundation Award
Impulse and Networking Fund of the Helmholtz Association (Helmholtz Excellence Network BioEM) Cluster for Systems Neurology German Research Foundation TRR274 Canadian federal funding agency (SSHRC) Canadian federal funding agency (NSERC) Canadian federal funding agency (CIHR) New Frontiers in Research Fund Transformation grant European Research Council (advanced grant NeuroCentro) DKH DFG funding (German Research Foundation) German Research Foundation